2024. A Signature of Pre-Operative Biomarkers of Cellular Senescence to Predict Risk of Cardiac and Kidney Adverse Events after Cardiac Surgery. Cardiology and Cardiovascular Medicine. 8, 3 (Jun. 2024), 267–274.